2014
DOI: 10.1016/j.ijrobp.2014.02.032
|View full text |Cite
|
Sign up to set email alerts
|

Similar Survival for Patients Undergoing Reduced-Intensity Total Body Irradiation (TBI) Versus Myeloablative TBI as Conditioning for Allogeneic Transplant in Acute Leukemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 18 publications
0
4
0
Order By: Relevance
“…Allogeneic haematopoietic stem cell transplantation (allo‐HSCT) is a potentially curative treatment for patients with haematological malignancies (Giralt et al., ; Majhail et al., ), which is increasingly being used worldwide (Nivison‐Smith et al., ; Passweg et al., ; Yoshimi et al., ). The standard procedure for myeloablative allo‐HSCT includes a conditioning regimen of high‐dose chemotherapy, often in combination with total‐body irradiation (TBI), followed by infusion of stem cells harvested from a donor's bone marrow or peripheral blood (Imamura & Shigematsu, ; Mikell et al., ). This conditioning regimen produces a 2–4 week period of cytopenia, characterised by severe leukopenia and thrombocytopenia, requiring the patient to be in a single‐bed isolation room for 4–6 weeks (Morishita, Kaida, Setogawa, et al., ).…”
Section: Introductionmentioning
confidence: 99%
“…Allogeneic haematopoietic stem cell transplantation (allo‐HSCT) is a potentially curative treatment for patients with haematological malignancies (Giralt et al., ; Majhail et al., ), which is increasingly being used worldwide (Nivison‐Smith et al., ; Passweg et al., ; Yoshimi et al., ). The standard procedure for myeloablative allo‐HSCT includes a conditioning regimen of high‐dose chemotherapy, often in combination with total‐body irradiation (TBI), followed by infusion of stem cells harvested from a donor's bone marrow or peripheral blood (Imamura & Shigematsu, ; Mikell et al., ). This conditioning regimen produces a 2–4 week period of cytopenia, characterised by severe leukopenia and thrombocytopenia, requiring the patient to be in a single‐bed isolation room for 4–6 weeks (Morishita, Kaida, Setogawa, et al., ).…”
Section: Introductionmentioning
confidence: 99%
“…[ 4 ] The unique advantage of TBI over conditioning regimens based on cytotoxic chemotherapy is that it has better tissue penetration since it is not dependent on either blood supply or hepatic/renal parameters; hence, even sanctuary sites such as central nervous system and testes are not spared. [ 5 6 7 8 ] The disadvantages associated with TBI are risks associated with acute and late toxicities including second malignancy which contributes to increased morbidity and mortality, need for specialized equipment, and challenging logistics of administration. [ 9 10 ] Recent developments have been focusing on simplifying treatment delivery, decreasing the risk of toxicity while achieving better efficacy.…”
Section: Introductionmentioning
confidence: 99%
“…For myeloablative conditioning, a prescribed dose ranging from 12 to 13.2 Gy has been commonly used to attenuate the immunity of the recipient and to destroy cancer cells [ 4 ]. For reduced-intensity stem cell transplantation (RIST) combined with TBI, a prescribed dose ranging from 2 to 6 Gy has been used [ 5 , 6 ]. To irradiate the whole patient body, various techniques, such as long source-to-surface distance (SSD), moving bed [ 7 , 8 ] and helical tomotherapy [ 9 , 10 ], have been used.…”
Section: Introductionmentioning
confidence: 99%